Recruiting OBSERVATIONAL NCT06258551

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

Sponsor: Baylor College of Medicine

Conditions Antibiotic Resistant Infection Antimicrobial Drug Resistance Carbapenem Resistant Bacterial Infection Carbapenem-Resistant Enterobacteriaceae Infection Clostridium Difficile Extended Spectrum Beta-Lactamase Producing Bacteria Infection Vancomycin Resistant Enterococci Infection Vancomycin-Resistant Enterococcal Infection

Updated 3 times since 2024 Last updated: Feb 6, 2024 Started: Dec 8, 2020 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06258551, this observational or N/A phase trial focuses on Antibiotic Resistant Infection and Antimicrobial Drug Resistance and remains actively recruiting participants. Sponsored by Baylor College of Medicine, it has been updated 3 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baylor College of Medicine
M.D. Anderson Cancer Center
National Institute of Allergy and Infectious Diseases (NIAID)
The Methodist Hospital Research Institute
The University of Texas Health Science Center, Houston
University of Houston
William Marsh Rice University

Data source: The Methodist Hospital Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States